Xylem Inc.
No SEC Form 4 filings for $XYL in the last 30 days.
See all $XYL insider activity →Stifel reduced Xylem's price target to $141 from $160, citing growth concerns. The stock has fallen 25% year-to-date, trading at $104.05. Despite challenges, Stifel maintains a Buy rating, expecting revenue growth in 2027. Xylem reported Q2 2026 earnings of $1.46 per share, beating estimates, and raised its full-year profit outlook.
JPMorgan reduced its price target for Xylem from $137 to $118. The stock is currently trading at $104.05, down 23.59% year-to-date. Mizuho also lowered its target to $110 from $130.
Oppenheimer maintained an Outperform rating on Xylem (XYL) with a $150 price target, suggesting a 46.3% upside from the Oct 13 close. The firm cited strong demand for water infrastructure and growth potential from M&A and core operations.
Over the past 7 days, AlphAI's AI scored 2 news stories mentioning XYL (Xylem Inc.). Coverage has skewed bearish: 0 bullish, 0 neutral, and 2 bearish.
Recent XYL coverage spans financial news and corporate actions.
Analyst target cut suggests weaker outlook.
Analyst downgrade may pressure the stock.
Analyst upgrade and higher price target may drive buying interest.
Despite operational beats, the stock decline suggests investors were disappointed by something not captured here, such as outlook details or positioning.
Analyst price‑target reduction suggests modest downside risk but still indicates upside potential.
AlphAI scores every news story that mentions XYL with an AI model for sentiment and relevance, and aggregates insider trades from Xylem Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Stifel reduced Xylem's price target to $141 from $160, citing growth concerns. The stock has fallen 25% year-to-date, trading at $104.05. Despite challenges, Stifel maintains a Buy rating, expecting revenue growth in 2027. Xylem reported Q2 2026 earnings of $1.46 per share, beating estimates, and raised its full-year profit outlook.
2 min readJPMorgan reduced its price target for Xylem from $137 to $118. The stock is currently trading at $104.05, down 23.59% year-to-date. Mizuho also lowered its target to $110 from $130.
1 min readOppenheimer maintained an Outperform rating on Xylem (XYL) with a $150 price target, suggesting a 46.3% upside from the Oct 13 close. The firm cited strong demand for water infrastructure and growth potential from M&A and core operations.
1 min readEnergy Recovery (ERII) reported Q2 revenue of $12M, down 57.2% YoY, missing estimates. Xylem (XYL) reported $2.34B revenue, up 1.5% YoY, meeting expectations. Mueller Water (MWA) reported $395.9M revenue, up 4.1% YoY, beating estimates. All stocks declined post-earnings.
5 min readXylem Inc.'s average stock price target was reduced by analysts from $152.8 to $151.2, with a range of $112 to $180. This implies a 47% upside from the Oct. 9 closing price. The consensus rating remains 'Buy' among 24 analysts.
1 min readCitigroup lowered its price target for Xylem from $172 to $148. The company's stock is currently trading at $102.71, with a 5-day change of +0.71% and a year-to-date change of -24.58%.
1 min readXylem Inc. (XYL) filed an SEC Form 8-K — Other Events. Item 8.01 Other Events On September 29, 2026, Xylem Inc. (the “Company”) completed a public offering (the “Offering”) of $500,000,000 aggregate principal amount of 5.250% Senior Notes due 2029 (the “2029 Notes”), $500,000,000 aggregate principal amount of 5.450% Senior Notes due
2 min readParker-Hannifin (PH) outperformed Xylem (XYL) with 6.3% YTD and 22.1% 52-week gains. Analysts rate XYL a 'Moderate Buy' with a $150.94 mean price target, implying 41.7% upside from current levels.
1 min readXylem Inc. (XYL) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement On September 8, 2026, Xylem Inc. (the “Company”), as borrower, entered into a Five-Year Revolving Credit Facility Agreement (the “2026 Credit Agreement”), a senior unsecured revolving credit facility, in an aggregate principal
1 min readCentene's CFO Drew Asher to step down by year-end, succeeded by Chris Neczypor. Baxter International names John Rogers as CFO. GE HealthCare appoints William K. Grogan as CFO. QVC Group's CEO David Rawlinson steps down, Mike George takes interim role. Changes impact leadership at Fortune 500 companies.
3 min read
